141 related articles for article (PubMed ID: 38022125)
1. Surgical Outcomes in Early-Stage Cervical Cancer Following Radical Hysterectomy in a Resource-Limited Setting: The Experience of the National Cancer Institute (Apeksha Hospital, Maharagama), Sri Lanka.
Wijeratne Y; Hapuachchige C
Cureus; 2023 Oct; 15(10):e47744. PubMed ID: 38022125
[TBL] [Abstract][Full Text] [Related]
2. Surgical Staging of Differentiated Endometrial Cancer: An Analysis of Postoperative Outcome in a Gynecological Cancer Center in Sri Lanka.
Wijesinghe RD; Patabendige M; Pakthagunanathan N; Hapuachchige C
Cureus; 2023 Jul; 15(7):e41605. PubMed ID: 37565096
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of cervical cancer in a resource-limited setting: One year of data from the National Cancer Institute, Sri Lanka.
Patabendige M; Wijesinghe RD; Wijesuriya MWAB; Hapuachchige C
Int J Gynaecol Obstet; 2021 Jan; 152(1):78-81. PubMed ID: 32961591
[TBL] [Abstract][Full Text] [Related]
4. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
5. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
6. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
[TBL] [Abstract][Full Text] [Related]
7. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
8. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
9. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
Yanaranop M; Sathapornteera N; Nakrangsee S
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
[TBL] [Abstract][Full Text] [Related]
11. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
Savino L; Borruto F; Comparetto C; Massi GB
Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
[TBL] [Abstract][Full Text] [Related]
12. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome.
Pellegrino A; Vizza E; Fruscio R; Villa A; Corrado G; Villa M; Dell'Anna T; Vitobello D
Eur J Surg Oncol; 2009 Jan; 35(1):98-103. PubMed ID: 18760562
[TBL] [Abstract][Full Text] [Related]
13. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
14. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis.
Turkmen O; Kilic F; Tokalioglu AA; Cakir C; Yuksel D; Kilic C; Boran N; Kimyon Comert G; Turan T
J Obstet Gynaecol; 2022 Oct; 42(7):3204-3211. PubMed ID: 35959796
[TBL] [Abstract][Full Text] [Related]
15. Tailored radical hysterectomy for locally advanced cervical cancer.
Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
[TBL] [Abstract][Full Text] [Related]
16. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic radical hysterectomy and pelvic lymphadenectomy can be routinely used for treatment of early-stage cervical cancer: a single-institute experience with 404 patients.
Yang L; Cai J; Dong W; Shen Y; Xiong Z; Wang H; Min J; Li G; Wang Z
J Minim Invasive Gynecol; 2015 Feb; 22(2):199-204. PubMed ID: 25281840
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
Metindir J; Bilir G
Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
